Hood River Capital Management LLC recently announced the acquisition of new stake in DocGo Inc. (NASDAQ:DCGO). The institutional investor has increased its shareholding in the Healthcare company by 27.12% to 5.57 million shares with purchase of 1.19 million shares. This fresh investment now brings its stake to 5.44% valued currently at $50.99 million. In addition, BlackRock Fund Advisors raised its holdings by 0.23 million to 5.18 million shares. And The Vanguard Group, Inc. has lifted its position by 1.01% or 39374.0 shares – to 3.94 million shares.
With over 2.78 million DocGo Inc. (DCGO) shares trading Tuesday and a closing price of $8.42 on the day, the dollar volume was approximately $23.45 million. The shares have shown a negative half year performance of -15.12% and its price on 03/14/23 lost nearly -3.22%. Currently, there are 98.96M common shares owned by the public and among those 85.28M shares have been available to trade.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
Insiders at the company have transacted a total of 16 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 10 of these insider trades were purchases, accounting for 1,936,184 shares. Insider sales of the common stock occurred on 6 occasions, with total insider shares sold totaling 3,254,986 shares.
The top 3 mutual fund holders in DocGo Inc. are Hood River Small-Cap Growth Fund, Vanguard Total Stock Market Index, and iShares Russell 2000 ETF. Hood River Small-Cap Growth Fund owns 2.54 million shares of the company’s stock, all valued at over $23.21 million. The company bought an additional 0.61 million shares recently to bring their total holdings to about 2.48% of the shares outstanding. iShares Russell 2000 ETF sold 5724.0 shares to bring its total holdings to over 1.81 million shares at a value of $16.52 million. iShares Russell 2000 ETF now owns shares totaling to 1.76% of the shares outstanding.
Shares of DocGo Inc. (NASDAQ: DCGO) opened at $9.50, up $0.8 from a prior closing price of $8.70. However, the script later moved the day high at 9.62, down -3.22%. The company’s stock has a 5-day price change of -6.44% and 27.77% over the past three months. DCGO shares are trading 19.09% year to date (YTD), with the 12-month market performance up to 27.77% higher. It has a 12-month low price of $4.96 and touched a high of $11.41 over the same period. DCGO has an average intraday trading volume of 680.87K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -7.67%, -4.93%, and -2.07% respectively.
Institutional ownership of DocGo Inc. (NASDAQ: DCGO) shares accounts for 38.60% of the company’s 98.96M shares outstanding. Mutual fund holders own 18.01%, while other institutional holders and individual stakeholders account for 25.59% and 17.07% respectively.
It has a market capitalization of $883.43M. The stock’s trailing 12-month PE ratio is 17.29, while the earnings-per-share (ttm) stands at $0.49. The company has a PEG of 0.56 and a Quick Ratio of 3.50 with the debt-to-equity ratio at 0.05. Price movements for the stock have been influenced by the stock’s volatility, which stands at 9.15% over the week and 5.17% over the month.
Analysts forecast that DocGo Inc. (DCGO) will achieve an EPS of $0.05 for the current quarter, $0.05 for the next quarter and $0.31 for 2023. The lowest estimate earnings-per-share for the quarter is $0.03 while analysts give the company a high EPS estimate of $0.06. Comparatively, EPS for the current quarter was $0.23 a year ago. Earnings per share for the fiscal year are expected to increase by 201.70%, and 10.07% over the next financial year.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 5 brokerage firm advisors rate DocGo Inc. (DCGO) as a “Strong Buy” at a consensus score of 1.60. Specifically, 5 Wall Street analysts polled rate the stock as a buy, while 0 of the 5 advise that investors “hold,” and 0 rated it as a “Sell.”
Looking at the support for the DCGO, a number of firms have released research notes about the stock. Deutsche Bank stated their Buy rating for the stock in a research note on April 19, 2022, with the firm’s price target at $11. Stifel coverage for the DocGo Inc. (DCGO) stock in a research note released on January 19, 2022 offered a Buy rating with a price target of $14. Canaccord Genuity was of a view on December 21, 2021 that the stock is Buy, while Needham gave the stock Buy rating on December 07, 2021, issuing a price target of $14.
